Valiant Laboratories bulk deals and insider trading
NSE: VALIANTLABBSE: 543998Pharmaceuticals & BiotechnologySmall Cap
Last close ₹128.43down ₹2.62 (2.00%)BSE ₹129.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹131.05.
52-week range of traded prices to 23 Oct 2026
₹49.51Low, 4 Mar 2026₹141.38High, 19 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹698 Cr2,048th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 43.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 2.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 5.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day.
- 9,957
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Valiant Laboratories promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Valiant Laboratories insider trading
All 14 disclosures on record.Insider trading, all companies
Sep 2026
- Paresh Shashikant Shah₹0.16 Cr16,922 sharesSold or invoked · Promoter And Designated Person · 2 Sep 2026 · disclosed 30 Sep
- CHANDRAKANT VALLABHAJI GOGRI₹0.16 Cr16,922 sharesBought · Designated Person · 2 Sep 2026 · disclosed 30 Sep
Aug 2026
- CHANDRAKANT VALLABHAJI GOGRI₹7.85 Cr10,00,000 sharesBought · Designated Person · 13 Aug 2026 · disclosed 30 Sep
- Paresh Shashikant Shah₹7.85 Cr10,00,000 sharesSold or invoked · Promoter And Designated Person · 13 Aug 2026 · disclosed 30 Sep
Dec 2025
- NIKHIL PARIMAL DESAI₹0.41 Cr56,145 sharesBought · Designated Person · 24 Dec 2025 · disclosed 31 Dec
- NIKHIL HOLDINGS PRIVATE LIMITED₹0.69 Cr1,00,000 sharesBought · Designated Person · 22 Dec 2025 · disclosed 26 Dec
- NIKHIL PARIMAL DESAI₹0.35 Cr50,000 sharesBought · Designated Person · 22 Dec 2025 · disclosed 26 Dec
- NIKHIL HOLDINGS PRIVATE LIMITED₹0.35 Cr50,000 sharesBought · Designated Person · 19 Dec 2025 · disclosed 23 Dec
- NIKHIL HOLDINGS PRIVATE LIMITED₹0.35 Cr50,000 sharesBought · Designated Person · 18 Dec 2025 · disclosed 22 Dec
Aug 2025
- Santosh Shantilal Vora₹7.17 Cr8,14,797 sharesBought · Promoter And Designated Person · 13 Aug 2025 · disclosed 18 Aug
- Dhanvallabh Ventures LLP₹45 Cr50,87,500 sharesBought · Promoter · 13 Aug 2025 · disclosed 18 Aug
- Paresh Shashikant Shah₹8.95 Cr10,16,922 sharesBought · Promoter And Designated Person · 13 Aug 2025 · disclosed 18 Aug
- Kanchan Shantilal Vora₹3.55 Cr4,03,672 sharesBought · Promoter · 13 Aug 2025 · disclosed 18 Aug
- Shantilal Shivji Vora₹7.17 Cr8,14,797 sharesBought · Promoter And Designated Person · 13 Aug 2025 · disclosed 18 Aug
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Valiant Laboratories bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹2.10 Cr bought and ₹0.05 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 17 Dec 20251 firm · ₹2.10 Cr bought · ₹0.05 Cr soldNet bought ₹2.05 Cr
- Both waysMETASONI ALLOYS PVT LTDBought 3,11,999 at ₹67.33Sold 7,742 at ₹66.980.57% of the companyNet +3,04,257 shares₹2.10 Cr bought
Friday 13 Jun 20251 firm · ₹0 bought · ₹2.83 Cr soldNet sold ₹2.83 Cr
- SoldTRADE CORNERSold 2,35,200 at ₹120.290.54% of the company₹2.83 Cr
Friday 31 Jan 20252 firms · ₹2.83 Cr bought · ₹2.83 Cr soldNet nil
- SoldMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDSold 2,75,000 at ₹102.750.63% of the company₹2.83 Cr
- BoughtNECTA BLOOM VCC - NECTA BLOOM ONEBought 2,75,000 at ₹102.750.63% of the company₹2.83 Cr
Friday 24 Jan 20252 firms · ₹5.82 Cr bought · ₹5.82 Cr soldNet nil
- BoughtMONEY LOGIX SECURITIES PVT LTDBought 5,50,000 at ₹105.781.27% of the company₹5.82 Cr
- SoldJAINAM BROKING LIMITEDSold 5,50,000 at ₹105.771.27% of the company₹5.82 Cr
Friday 7 Jun 20242 firms · ₹5.17 Cr bought · ₹4.92 Cr soldNet bought ₹0.25 Cr
- BoughtJALIYAN COMMODITYBought 3,49,143 at ₹142.810.80% of the company₹4.99 Cr
- Both waysJAINAM BROKING LIMITEDBought 12,300 at ₹148.54Sold 3,44,380 at ₹142.800.79% of the companyNet −3,32,080 shares₹0.18 Cr bought
Tuesday 16 Jan 20241 firm · ₹4.33 Cr bought · ₹3.05 Cr soldNet bought ₹1.29 Cr
- Both waysANANT WEALTH CONSULTANTS PRIVATE LIMITEDBought 2,37,572 at ₹182.45Sold 1,65,635 at ₹184.090.55% of the companyNet +71,937 shares₹4.33 Cr bought
Friday 12 Jan 20241 firm · ₹0 bought · ₹5.74 Cr soldNet sold ₹5.74 Cr
- SoldLEADING LIGHT FUND VCC THE TRIUMPH FUNDSold 3,26,000 at ₹176.160.75% of the company₹5.74 Cr
Tuesday 26 Dec 20231 firm · ₹4.98 Cr bought · ₹0 soldNet bought ₹4.98 Cr
- BoughtVIKASA INDIA EIF I FUND - INCUBE GLOBAL OPPORTUNITIESBought 2,82,000 at ₹176.640.65% of the company₹4.98 Cr
Friday 6 Oct 20234 firms · ₹19 Cr bought · ₹8.52 Cr soldNet bought ₹11 Cr
- BoughtNIRAJ RAJNIKANT SHAHBought 6,50,000 at ₹162.15₹11 Cr
- BoughtPRABHULAL LALLUBHAI PAREKHBought 5,29,365 at ₹168.32₹8.91 Cr
- SoldALPHA ALTERNATIVES MSAR LLPSold 2,99,127 at ₹162.84₹4.87 Cr
- SoldALPHA ALTERNATIVES FINANCIAL SERVICES PRIVATE LIMITEDSold 2,24,127 at ₹163.01₹3.65 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 17 deals on record since listing on 6 Oct 2023.